基金Acknowledgments We thank M Hamaguchi (Nagoya Univ., Japan) and T Iwahara (Osaka Bioscience Institute, Japan) forJak null MEFs, and N Gotoh (Tokyo Univ., Japan), H Higashi (Hokkaido Univ., Japan), N Mochizuki (National Cardiovascular Cent. Res. Inst., Japan), H Hanafusa (Prof. emeritus, The Rockefeller Univ., USA and Direc- tor em., OBI, Japan), SK Hanks (Vanderbilt Univ., USA), and M Matsuda (Kyoto Univ., Japan) for plasmids. We also thank K Sasai (Hokkaido Univ., Japan) and Y Ohba (Hokkaido Univ., Japan) for valuable discussion. This work was supported in part by grants-in- aid from the Ministry of Education, Science, Culture, and Sports, and the Ministry of Health, Labor, and Welfare, Japan, as well as Suhara Memorial Foundation (Sapporo, Japan), and the Mochida Medical Science Foundation (Tokyo, Japan). The work of SF and TK is supported by grants from Cancer Research UK and the Brit- ish Cancer Charity "Heads Up". We dedicate this work to our great mentor Hidesaburo Hana- fusa, professor emeritus of the Rockefeller University, who passed away on March 15, 2009 at the age of 79. He devoted his life to science and in particular to creating the oncogene research field, to teaching and to providing profound affection to his students and postdocs. All of the alumni of Saburo's laboratory pride them- selves in having been his apprentices and we would like to hereby express our deeply felt
gratitude to Saburo.